Celsee Diagnostics Adds Another Patent to IP Portfolio
“System for Imaging Captured Cells” was assigned U.S. fundas iphone 5 5s se fundas samsung galaxy s8 fundas huawei y6 2017 fundas huawei p8 lite 2017 Patent No. fundas samsung galaxy s9 plus fundas huawei y5 2019 fundas huawei p30 lite 9404864 Celsee Diagnostics, an innovator of cutting-edge liquid-biopsy products announced today the receipt of another patent. fundas huawei y6 2018 fundas iphone 7 8 plus fundas huawei p8 lite The patent, “System for Imaging Captured Cells”, applies to the Celsee ANALYZER imaging platform, and was assigned U.S. fundas iphone fundas iphone 11 pro max fundas huawei p8 fundas samsung galaxy a40 fundas samsung galaxy s4 Patent No. fundas huawei mate 20 pro fundas samsung galaxy s7 edge bracelet perle 9404864 by the United States Patent and Trademark Office (USPTO). fundas iphone 11 fundas huawei mate 20 fundas samsung galaxy s20 plus fundas iphone x xs iphone 7 hoesjes fundas iphone 5 5s se The patent covers innovations of Celsee Diagnostics’ automated brightfield and multiplex fluorescence imaging system used for whole slide imaging. coque iphone iphone hoesjes fundas samsung galaxy a50 fundas samsung galaxy s20 plus fundas huawei p20 lite fundas huawei p20 pro fundas huawei p8 Using the system, circulating tumor cells (CTCs) captured in a proprietary microfluidic chip (slide) are automatically imaged to provide both biomarker and morphological information of the rare cells. fundas iphone 5 5s se fundas samsung galaxy note5 The technology embodied in the Celsee ANALYZER platform provides imaging precision and accuracy as well as ease of use and simplicity. custodia cover samsung fundas samsung galaxy s10 fundas huawei y5 2018 iphone 8 plus hoesjes fundas iphone 11 pro max fundas iphone 11 pro Celsee Diagnostics’ automated CTC preparation instrument, Celsee PREP400, processes 4 samples simultaneously; the Celsee ANALYZER analyzes up to 8 microfluidic chips per run. fundas iphone 6 6s fundas samsung galaxy s6 edge custodia cover iphone fundas huawei p8 fundas huawei p30 fundas iphone 11 “The issuance of this patent validates the technological advancements embodied in our product offering; in this particular instance the Celsee ANALYZER imaging platform. fundas samsung galaxy s7 edge fundas iphone 11 pro fundas huawei p9 custodia cover samsung fundas iphone 11 coque iphone 7 Accuracy, precision and reproducibility are critical elements needed to accelerate the acceptance of liquid biopsy and rare cell analysis as a cost-effective prognosis and monitoring tool. fundas iphone 11 pro max fundas huawei p9 coque iphone 6 fundas samsung galaxy a5 fundas iphone xr Platforms must be state of the art yet easy-to-use,” said Celsee Diagnostics’ President and Chief Executive Officer Kalyan Handique. fundas samsung galaxy a3 fundas iphone xr fundas iphone 11 pro About Celsee Diagnostics Celsee Diagnostics, a privately-held Michigan-based company, develops automated systems for rare CTC enrichment and single-cell analysis. fundas huawei y6 2018 fundas samsung galaxy note9 The company’s precise, accurate, and reliable platform for research and clinical diagnostics development will allow healthcare professionals more time to focus on their patients’ therapeutic treatment and outcomes. fundas huawei p10 lite fundas samsung galaxy s6 fundas huawei y6 2019 fundas huawei p8 lite The label-free Celsee PREP platforms perform all the required processing steps to isolate and execute downstream single-cell analysis including immunochemistry, DNA FISH and mRNA FISH, while the Celsee ANALYZER scans and analyzes the prepared slide automatically. fundas iphone xr For more information, visit www.celsee.com. fundas samsung galaxy s7 fundas samsung galaxy a70 fundas samsung galaxy s20 plus custodia samsung fundas huawei p9 lite Media Contact: Nicole Litchfield Bioscribe, Inc.